Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic Leukemia
NCT03005392 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2016-12-29
Summary
* Exercise programs in children and teenagers with Acute Lymphoblastic Leukemia (ALL) strengthens their physical fitness.
* Exercising improves muscular and functional mobility fitness after finalizing chemotherapy in children and teenagers diagnosed with ALL.
* Assess cardiological changes
Conditions
Interventions
- OTHER
-
exercise
An exercise program will be designed over 16 weeks with 55 sessions, moderately increasing the volume and intensity of the load every 4 weeks. The program will consist of strength exercises, flexibility and aerobic endurance, which will be explained in videos and are going to be available in an online platform. The physiotherapist will contact the patient and/or tutor weekly so as to answer and doubts they may have with respect to the exercise program and to further supervise their compliance (group with intervention).
Sponsors & Collaborators
-
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 7 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2015-09-30
- Completion
- 2016-03-31
Countries
- Spain
Study Locations
More Related Trials
-
ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients
NCT01901367 ·Status: COMPLETED ·Phase: NA
-
Reduce Sedentary Time in Acute Lymphoblastic Leukemia
NCT06182163 ·Status: COMPLETED ·Phase: NA
-
Endothelial Function, Arterial Stiffness and Components
NCT01439217 ·Status: COMPLETED
-
Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia
NCT03985826 ·Status: COMPLETED
-
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
NCT05639673 ·Status: RECRUITING
-
Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
NCT03035344 ·Status: UNKNOWN
-
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
NCT04179929 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia
NCT02345915 ·Status: UNKNOWN ·Phase: NA
-
Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma
NCT00866749 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol
NCT04677231 ·Status: UNKNOWN
-
Targeted High Throughput Sequencing in the Diagnosis of Pediatric Acute Leukemia
NCT01991249 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00343369 ·Status: UNKNOWN ·Phase: NA
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
NCT00002499 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of the Medullary Microenvironment in Acute Childhood Leukemia
NCT05792007 ·Status: RECRUITING ·Phase: NA
-
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies
NCT05772559 ·Status: RECRUITING
-
LAL-BR/2001: Study Treatment to Low Risk ALL
NCT00526175 ·Status: COMPLETED ·Phase: PHASE4
-
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT03911128 ·Status: RECRUITING
-
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
NCT00494897 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases
NCT03959007 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
NCT00005945 ·Status: COMPLETED ·Phase: PHASE3
-
Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.
NCT06608732 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
NCT06785324 ·Status: RECRUITING ·Phase: NA
-
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT00131053 ·Status: UNKNOWN ·Phase: PHASE2
-
Microcirculation in Patients With Leukemic Hyperleukocytosis
NCT03729206 ·Status: COMPLETED ·Phase: NA
-
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
NCT03808610 ·Status: TERMINATED ·Phase: PHASE1/PHASE2